Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18.55 USD | +1.09% | -4.43% | 0.00% |
Jun. 05 | ArriVent, Alphamab Unit to Collaborate on Antibody Drug Conjugates For Cancer Treatment | MT |
Jun. 05 | Alphamab Strikes Deal with Nasdaq-Listed ArriVent to Co-Develop Antibody Drug Conjugates | MT |
Official Publications
No official publication found
- Stock Market
- Equities
- AVBP Stock
- News ArriVent BioPharma, Inc.
- Official Publications